Neovascular age-related macular degeneration is a serious eye disease that causes rapid loss of central vision, making it difficult to read, recognize faces, or drive. Though it affects millions worldwide, treatments can help preserve remaining sight and maintain independence.
Understanding Neovascular Age-Related Macular Degeneration
Neovascular age-related macular degeneration, often called wet AMD or nvAMD, is a progressive disease affecting the central part of the retina known as the macula — the area responsible for sharp, detailed vision. Unlike the more common dry form of age-related macular degeneration, wet AMD develops when abnormal, fragile blood vessels grow beneath the macula in an uncontrolled manner. These newly formed vessels are weak and prone to leaking blood and fluid, which damages the delicate tissue responsible for central vision.[1][2]
The term “neovascular” refers to this abnormal growth of new blood vessels, a process doctors call neovascularization or choroidal neovascularization. When these vessels leak, they cause swelling, bleeding, and eventually scarring of the macula. This scarring can permanently destroy the normal structure of the outer retina, leading to irreversible loss of central vision. Over time, the leaked fluid can form a bulge in the macula, creating dark or blurry areas in a person’s central field of view.[3][4]
While wet AMD represents the less common form of age-related macular degeneration — affecting only about 10% of all AMD patients — it is responsible for nearly 90% of severe vision loss associated with the disease. This is because wet AMD progresses much more rapidly than dry AMD, sometimes causing noticeable vision changes within days or weeks. Any stage of dry AMD can suddenly transform into wet AMD, making it crucial for people with any form of macular degeneration to monitor their vision closely.[1][6]
How Common Is This Condition
Age-related macular degeneration stands as one of the leading causes of blindness and severe visual impairment worldwide, particularly in developed nations. The disease primarily affects older adults, with wet AMD being most prevalent among people over age 60. Current estimates suggest that neovascular AMD affects approximately 20 million people globally, though this figure represents a portion of the total 196 million people estimated to have some form of AMD worldwide as of 2020.[1][2]
The global burden of this disease continues to grow significantly. Researchers project that the number of people with age-related macular degeneration will reach 288 million by 2040. This dramatic increase stems largely from two factors: people around the world are living longer, and Western dietary patterns and lifestyles are becoming more widespread in developing nations. As populations age, the number of individuals at risk for developing wet AMD increases proportionally.[1][6]
AMD accounts for approximately 8.7% of all blindness worldwide, making it a major public health concern. In the United States alone, nearly 20 million adults have some form of macular degeneration, with the condition being the most common cause of significant vision loss in people over 50 in developed countries. In the United States specifically, about 200,000 new cases of neovascular AMD are diagnosed each year, highlighting the ongoing impact of this condition on aging populations.[1][4][9]
The disease shows clear demographic patterns. Europeans have the highest prevalence of AMD compared to African, Hispanic, and Asian populations. Among all forms of AMD, early-stage disease is more common in people with European ancestry (11.2%) than in Asians (6.8%), though the prevalence of late-stage AMD — which includes wet AMD — shows no significant difference between these groups. People with African ancestry have lower rates of AMD overall.[1][9]
What Causes Neovascular AMD
The exact cause of neovascular age-related macular degeneration remains incompletely understood, though researchers have identified several biological processes involved in its development. The disease occurs when the eye ages and certain changes begin affecting the layers beneath the retina. One key change involves the thickening of a membrane called Bruch’s membrane, which lies between the retina and the layer of blood vessels that supplies it with oxygen and nutrients (the choroid). This thickening happens because lipids (fats) and proteins accumulate over time, creating deposits called drusen under the retinal pigment epithelium, a layer of cells that supports the macula.[1]
As Bruch’s membrane thickens and drusen accumulate, the macula receives fewer nutrients and becomes thinner and less healthy. In some cases, this triggers an abnormal response: the growth of new, fragile blood vessels attempting to supply the oxygen-starved tissue. Unfortunately, these vessels are structurally defective and leak easily. A protein called vascular endothelial growth factor (VEGF) plays a central role in promoting this abnormal blood vessel growth. VEGF is a family of compounds in the body that normally helps regulate blood vessel formation, but in wet AMD, it causes excessive and uncontrolled neovascularization that damages rather than helps the macula.[1][4][9]
The progression from healthy macula to wet AMD involves complex interactions between kinases (enzymes), cytokines (signaling molecules), and multiple growth factors. Among these, VEGF and its receptors have received the most attention because of VEGF’s dominant capacity to promote both new blood vessel growth and increased vascular permeability — the tendency for vessels to leak fluid. This understanding has led to the development of treatments specifically targeting VEGF to control the disease.[9]
Risk Factors for Developing Wet AMD
Age stands as the strongest risk factor for developing neovascular AMD. The disease is most common in people aged 55 and older, with risk increasing substantially after age 60. This age-related pattern has given the condition its name, though younger people can occasionally develop macular degeneration due to other factors. As people live longer, more individuals enter the age range where AMD becomes increasingly likely.[2][4][6]
Genetics play a significant role in AMD risk. Having a family history of age-related macular degeneration substantially increases your chances of developing the condition yourself. Researchers have identified several genetic variations that make some individuals more susceptible to AMD, though having these genetic markers doesn’t guarantee you’ll develop the disease. The hereditary component means that people with close relatives who have AMD should be especially vigilant about regular eye examinations.[4][6]
Race and ethnicity influence AMD risk in notable patterns. Caucasian individuals face higher risk compared to people of other racial backgrounds. Studies show that AMD is more common among white populations than among African, Hispanic, or Asian groups. This racial disparity in disease prevalence may reflect both genetic differences and varying environmental or lifestyle exposures among different populations.[1][2][6]
Smoking represents one of the most significant modifiable risk factors for AMD. People who smoke cigarettes are two to five times more likely to develop age-related macular degeneration compared to non-smokers. The chemicals in tobacco smoke can damage blood vessels and reduce oxygen delivery to the retina, potentially triggering or accelerating the disease process. The good news is that quitting smoking can reduce this risk, making it one of the most important preventive steps a person can take.[2][4]
Gender appears to play a role, with women facing higher risk than men. The reasons for this difference aren’t entirely clear but may relate to hormonal factors or the fact that women tend to live longer than men, giving them more years in the high-risk age range. Other lifestyle and health factors that may increase AMD risk include obesity, high cholesterol levels, cardiovascular disease, high blood pressure, and a diet low in fish and lacking in certain nutrients like lutein and zeaxanthin. Some studies suggest that far-sightedness, light-colored irises, lower education levels, and significant sunlight exposure might also contribute to increased risk, though evidence for these factors varies.[2][4][6]
Recognizing the Symptoms
The symptoms of neovascular AMD often appear suddenly and progress rapidly, distinguishing wet AMD from the slower-developing dry form. Many people first notice that straight lines no longer appear straight — edges of doors, window frames, or lines of text may look wavy, bent, or distorted. This distortion, called metamorphopsia, occurs when fluid accumulating under the macula disrupts its normally flat surface, warping the visual signals it sends to the brain.[2][6]
Another common early symptom involves the appearance of blurry areas or dark spots in central vision. People might notice a gray, black, or empty patch developing right in the middle of their visual field. This spot or blur makes it difficult to see details directly in front of you, while vision to the sides remains clear. Over time, this blurry area may expand, making central vision increasingly impaired. Some people describe seeing a persistent shadow or missing section when they look at objects or try to read.[2][4][6]
A decrease in color intensity or brightness is another symptom some people experience. Colors may seem less vibrant or washed out, and distinguishing between similar shades becomes more difficult. Vision problems may worsen in low lighting conditions, making it harder to see in dimly lit rooms or at dusk. Some individuals notice that their central vision becomes blurry for both near and distance tasks, affecting activities like reading, driving, recognizing faces, or watching television.[2][6]
The speed of symptom development sets wet AMD apart from dry AMD. While dry AMD typically causes gradual vision changes over months or years, wet AMD can cause noticeable vision loss within days or weeks. This rapid progression means that prompt medical attention is crucial. Some people experience a sudden loss of central vision, while others notice their vision deteriorating more gradually. Either way, any new distortion of straight lines or appearance of blank spots warrants immediate contact with an eye care professional.[4][6]
It’s important to understand that wet AMD affects central vision while leaving peripheral vision intact. People with wet AMD can still see things off to the sides — they don’t experience tunnel vision. Instead, it’s as if someone placed a blurry or dark patch right in the center of their view, blocking details while the surrounding vision remains relatively normal. This pattern of vision loss creates specific challenges: reading becomes difficult because you can’t see the words directly in front of you, recognizing faces becomes problematic, and activities requiring detailed central vision become increasingly challenging.[3][6]
Prevention and Reducing Risk
While there is no guaranteed way to prevent neovascular age-related macular degeneration, several lifestyle modifications can reduce your risk or slow disease progression if you already have early signs of AMD. The most impactful preventive measure involves smoking cessation. Given that smokers face two to five times higher risk of developing AMD, quitting smoking represents the single most effective step you can take to protect your vision. The harmful effects of smoking on eye health are well-documented, and stopping can reduce your risk significantly.[2][13]
Diet plays an important role in eye health and AMD prevention. Eating a balanced, nutritious diet rich in specific foods may help protect against AMD or slow its progression. Leafy green vegetables like spinach and kale contain high levels of lutein and zeaxanthin, compounds that concentrate in the macula and may help protect it from damage. Fish, particularly fatty fish like salmon, provide omega-3 fatty acids that support retinal health. A diet abundant in fruits, vegetables, and fish while low in saturated fats aligns with recommendations for reducing AMD risk.[2][6][13]
Regular physical exercise contributes to overall cardiovascular health, which in turn supports eye health. Exercise helps maintain healthy blood pressure and circulation, both important for delivering oxygen and nutrients to the retina. Maintaining a healthy weight is also recommended, as obesity has been identified as a possible risk factor for AMD. Even moderate physical activity, if done regularly, can provide protective benefits.[2][13]
Managing other health conditions helps reduce AMD risk. Controlling high blood pressure and high cholesterol through medication or lifestyle changes protects blood vessels throughout the body, including those in and around the eye. Cardiovascular disease has been linked to increased AMD risk, so taking care of your heart health benefits your eyes as well.[4][6][13]
For people who already have intermediate AMD or early signs of the disease, specific dietary supplements may help prevent progression to advanced stages. These supplements typically include vitamins C and E, zinc, copper, lutein, and zeaxanthin. However, these supplements aren’t appropriate for everyone — some contain high doses that can cause side effects or interact with medications. It’s essential to consult with your doctor or eye specialist before starting any supplement regimen for AMD. They can advise whether supplements are right for your specific situation.[13][14]
Perhaps the most important preventive strategy involves regular eye examinations. Annual comprehensive eye exams, particularly for people over 50 or those with risk factors, allow eye doctors to detect early AMD before symptoms appear. Dilated retinal examinations can reveal drusen, changes in the macula, or early neovascularization, enabling earlier intervention. People with AMD in one eye should be especially vigilant, as they face increased risk of developing it in the other eye. Regular screening means that if wet AMD does develop, it can be caught and treated quickly, potentially preserving more vision.[2][6][14]
How the Disease Affects the Eye
Understanding what happens inside the eye during neovascular AMD helps explain why the disease causes such specific vision problems. The macula, located at the center of the retina in the back of the eye, measures only about 5 millimeters in diameter but contains the highest concentration of light-sensing cells called cones. These cones enable sharp, detailed color vision and are responsible for all the precise visual tasks we perform — reading, recognizing faces, threading a needle, or any activity requiring fine detail. When disease damages the macula, these critical visual functions suffer while peripheral vision, controlled by other parts of the retina, remains intact.[2][6]
The disease process begins beneath the retina. Normally, the retinal pigment epithelium (a layer of cells) sits on Bruch’s membrane, which separates it from the choroid — a layer rich in blood vessels that supplies oxygen and nutrients to the outer retina. As people age, waste products and lipids accumulate in Bruch’s membrane, making it thicker and less permeable. This buildup forms yellow deposits called drusen, visible during eye examinations. The accumulation interferes with nutrient exchange between the choroid and the retinal cells above.[1]
In response to this impaired nutrient supply, the eye’s tissues produce increased amounts of vascular endothelial growth factor (VEGF). Under normal circumstances, VEGF helps maintain healthy blood vessels and promotes new vessel growth when needed for healing. But in wet AMD, excessive VEGF production triggers uncontrolled growth of new blood vessels from the choroid that push through Bruch’s membrane toward the macula. This process is called choroidal neovascularization or macular neovascularization.[4][9]
These newly formed vessels are abnormally fragile and poorly constructed. Unlike mature, healthy blood vessels with strong walls, these vessels have structural defects that make them extremely leaky. They seep blood, fluid, and lipids into and under the retina, causing separation of the retinal layers and accumulation of fluid where it doesn’t belong. This fluid buildup causes the macula to swell and creates a bulge that distorts the normally smooth retinal surface. The mechanical distortion warps images, making straight lines appear wavy and creating blind spots or blurred areas in central vision.[3][4]
When blood vessels bleed into the macula, the released blood not only physically displaces tissue but also triggers inflammatory responses. Over time, the body attempts to clean up this damage by forming scar tissue. Unfortunately, this disciform scar replaces the normal, functioning architecture of the outer retina with non-functional fibrous tissue. Once this scarring occurs, the vision loss becomes permanent because the light-sensing photoreceptor cells and supporting cells in that area have been destroyed and cannot regenerate. This is why early detection and treatment are so crucial — treatment aims to stop the vessel leakage and prevent scarring before irreversible damage occurs.[4]
The physical changes in the eye directly translate to visual symptoms. Fluid under the macula creates the metamorphopsia (wavy lines) patients experience. Bleeding creates dark spots or shadows in vision. Progressive death of photoreceptor cells from chronic fluid exposure, poor oxygenation, or scarring creates expanding areas of vision loss. The speed at which these changes occur in wet AMD — sometimes over days or weeks — reflects how rapidly the abnormal vessels can leak and how quickly damage accumulates when blood and fluid continuously seep into delicate retinal tissue.[6]
